<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2006 (10) TMI 476 - DELHI HIGH COURT</title>
    <link>https://www.taxtmi.com/caselaws?id=196935</link>
    <description>In an interlocutory trademark dispute involving pharmaceutical products, prima facie deceptive similarity was assessed with heightened caution because confusion can affect health. Although the marks &quot;LOPARIN&quot; and &quot;LOPRIN&quot; showed some phonetic and visual resemblance, the products differed materially in nature, administration, packaging, price, and therapeutic use, with one being an oral preventive tablet and the other an injectable critical-care medicine. The court also considered delay, alleged acquiescence, and the defendants&#039; established sales and market presence, and found the balance of convenience supported the defendants. The ex parte interim injunction was vacated, and continued restraint was declined, subject to yearly sales statements.</description>
    <language>en-us</language>
    <pubDate>Wed, 04 Oct 2006 00:00:00 +0530</pubDate>
    <lastBuildDate>Thu, 22 Feb 2018 11:34:00 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=500441" rel="self" type="application/rss+xml"/>
    <item>
      <title>2006 (10) TMI 476 - DELHI HIGH COURT</title>
      <link>https://www.taxtmi.com/caselaws?id=196935</link>
      <description>In an interlocutory trademark dispute involving pharmaceutical products, prima facie deceptive similarity was assessed with heightened caution because confusion can affect health. Although the marks &quot;LOPARIN&quot; and &quot;LOPRIN&quot; showed some phonetic and visual resemblance, the products differed materially in nature, administration, packaging, price, and therapeutic use, with one being an oral preventive tablet and the other an injectable critical-care medicine. The court also considered delay, alleged acquiescence, and the defendants&#039; established sales and market presence, and found the balance of convenience supported the defendants. The ex parte interim injunction was vacated, and continued restraint was declined, subject to yearly sales statements.</description>
      <category>Case-Laws</category>
      <law>Indian Laws</law>
      <pubDate>Wed, 04 Oct 2006 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=196935</guid>
    </item>
  </channel>
</rss>